Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades

Head Neck. 2016 May;38(5):743-50. doi: 10.1002/hed.23942. Epub 2015 Jun 25.

Abstract

Background: This study provides Australian data on the characteristics of human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (SCC) over the last 2 decades.

Methods: The HPV status of 515 patients with oropharyngeal SCC diagnosed between 1987 and 2010 was determined by HPV E6-targeted multiplex real time polymerase chain reaction assay (PCR) and p16 immunohistochemistry.

Results: The HPV positivity rate increased from 20.2% (1987-1995) to 63.5% (2006-2010). Among HPV-positive oropharyngeal SCC over the study period, the median age increased from 55.4 years to 59.8 years (p = .004) and there was a trend of an increasing proportion of never smokers (19.2% to 34.0%). The use of radiation therapy (RT) in patients with HPV-positive oropharyngeal cancer increased from 26.9% to 68.1% (p = .007) and we also observed a trend of improved outcomes.

Conclusion: Our data show a rising prevalence of HPV-positive oropharyngeal SCC in Australia over the last 2 decades. These patients with HPV-positive oropharyngeal SCC are now presenting at an older age and about one third have never smoked.

Keywords: head and neck cancer; human papillomavirus (HPV); oropharyngeal cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Australia / epidemiology
  • Carcinoma, Squamous Cell / epidemiology*
  • Carcinoma, Squamous Cell / virology
  • DNA, Viral
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Multiplex Polymerase Chain Reaction
  • Oncogene Proteins, Viral / genetics
  • Oropharyngeal Neoplasms / epidemiology*
  • Oropharyngeal Neoplasms / virology
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / epidemiology*
  • Papillomavirus Infections / virology
  • Prevalence

Substances

  • DNA, Viral
  • E6 protein, human papillomavirus type 1
  • Oncogene Proteins, Viral